Analog Pharma Canada, a pharmaceutical company specializing in generic medicines for rare and ultra-rare diseases as well as generic versions of products owned by Duchesnay, has launched its first product, PrALOG-Doxylamine/PyridoxineTM (doxylamine succinate and pyridoxine hydrochloride), designed specifically for pregnant women. This launch represents a significant milestone for Analog Pharma Canada as it enters the pharmaceutical market with a generic alternative to Duchesnay Pharmaceutical Group’s flagship medication, PrDiclectin®. It also underscores the company’s ongoing commitment to women’s health and highlights the expertise based in Quebec that continues to support Canadian patients.
Health Technology Insights: SK bioscience Files IND for 2-Dose Varicella Vaccine Trial
Dany Hallé, Vice President of Commercial Affairs at Duchesnay Pharmaceutical Group, emphasized the company’s long-standing experience in maternal health and expressed confidence in developing a strong portfolio of affordable, high-quality treatments. He noted the current challenges in global supply chains due to geopolitical factors and stressed the importance of local manufacturing to ensure the steady availability of PrALOG-Doxylamine/PyridoxineTM for Canadian patients.
Founded in January 2024, Analog Pharma Canada was created to improve access to essential medicines by developing generic versions of Duchesnay’s products and providing access to other rare disease treatments. These medicines are developed through collaborations with leading global life sciences companies and meet rigorous standards of safety, efficacy, and affordability.
Health Technology Insights: LPOXY Raises $28 Million Series A to Fund STOP-Cdiff Trial
Frank Olivier Labelle, Associate Director of Analog Pharma Canada, highlighted the importance of this launch as a key step in fulfilling the company’s mission to expand access to affordable, reliable medications. He shared the company’s goal to support healthcare providers, enhance patient care, and contribute to building a stronger, more resilient supply chain within the Canadian healthcare system.
PrALOG-Doxylamine/PyridoxineTM is indicated for managing nausea and vomiting during pregnancy. The most common side effect associated with doxylamine succinate is drowsiness. Pyridoxine, a form of vitamin B6, is generally considered safe and has no known adverse effects. This product aims to offer pregnant women an effective and affordable option for managing common pregnancy symptoms.
Health Technology Insights: Elsevier Unveils PharmaPendium AI for Drug Development
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
